ARCHIVES

Two-Year Remission While Taking Gleevec Puts Patients Into Normal Mortality Rate

This article is from The Cancer Letter archive.

Vol. 34 No. 3 | March 25, 2011

Download PDF Visit The Full Archive

Related Articles

Two Avastin Trials Show OS Benefit In Advanced Disease

August 27, 2010

No Proof Fiber Is Anticarcinogenic, Newell Says, But diet should Include Anyway

May 18, 1979

In Brief: Peter Vogt Names Bristol-Myers Winner; Other Awards: Koop, Weinberg, Wynder, Longmire

March 24, 1989

DCPC Board Finally Approves Prescribe for Health Concept on 7-4 Vote, Okays RFA On Micronutrients

October 21, 1988

An Appreciation: Eddie Reed, 60, a Developer of Taxol

June 6, 2014

NHLBI Advisers Commit Funding TO NCI’s Women’s Health Trials, Tamoxifen Trial

March 8, 1991